Cooper J., Slogoff S.Haemodilution and priming solutions for cardiopulmonary bypass. In: Gravlee GP, Davis RF, Utley JR eds. Cardiopulmonary bypass. Baltimore: Williams and Wilkins, 1993: 124-37.
von Segesser LK, Weiss B., Turina MIPerfusion with heparin coated equipment: potential for clinical use. Semin Thorac Cardiovasc Surg1990; 2: 373-80.
4.
von Segesser LK, Weiss BM, Turina MIPerfusion with low systemic heparinization during resection of descending thoracic aortic aneurysms. Eur J Cardiothorac Surg1992; 6: 246-50.
5.
von Segesser LK, Weiss BM, Garcia E. et al. Reduction and elimination of systemic heparinization during cardiopulmonary bypass. J Thorac Cardiovasc Surg1992; 103: 790-99.
6.
von Segesser LK, Weiss BM, Pasic M., Garcia E., Turina MIRisk and benefit of low systemic heparinization during open heart surgery. Ann Thorac Surg1994; 58: 391-98.
7.
Nossel HLRadioimmunoassay of fibrinopeptides in relation to intravascular coagulation and thrombosis. N Engl J Med1976; 295: 428-32.
8.
von Segesser LK, Lachat M., Gallino A. et al. Performance characteristics of centrifugal pumps with heparin surface coating. Thorac Cardiovasc Surg1990;38:224-28.
9.
Bianchi JJ, Swartz MT, Braun PR, Illies MZ, Barnett MG, Pennington DGInitial experience with centrifugal pumps coated with the Carmeda process . ASAIO Journal1992; 38: M143-M146.
10.
von Segesser LK, Weiss BM, Hänseler E. et al. Improved biocompatibility of heparin surface coated ventricular assist devices. Int J Artif Organs1992; 15: 301-306.
